B
BillionToOne Team
BillionToOne
Last updated: February 23, 2026
BillionToOne is a precision diagnostics company that makes molecular diagnostics. Healthcare Medical Biotech
Y Combinator, $125M Series C in 2022
BillionToOne is a precision diagnostics company that makes molecular diagnostics. Healthcare Medical Biotech
Y Combinator, $125M Series C in 2022
- Series C • Y Combinator, $125M Series C in 2022
Founder Intelligence Brief: BillionToOne Team
This profile is built to help readers move from a founder name to decision-ready context. BillionToOne Team is mapped to BillionToOne in the Healthcare category, with current stage context as Series C. The primary operating market is San Francisco Bay Area, California, USA, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $125.00M, with the latest mapped round as Series C (Y Combinator, $125M Series C in 2022). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Healthcare startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Healthcare industry routes and Series C stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: United States directory.
- Stage signal: Series C funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Healthcare.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About BillionToOne Team
Common questions people ask about this profile.
Who is BillionToOne Team?
BillionToOne Team is the founder profile listed on 100Xfounder for BillionToOne, tracked for market signals, company intelligence, and operator-level context.
What does BillionToOne do?
BillionToOne is a precision diagnostics company that makes molecular diagnostics. Healthcare Medical Biotech
Where is BillionToOne based?
BillionToOne is listed as operating from San Francisco Bay Area, California, USA.
What is the current funding stage of BillionToOne?
BillionToOne is currently categorized at Series C on 100Xfounder. Funding signal: Y Combinator, $125M Series C in 2022
What is the latest funding round for BillionToOne?
The latest tracked round for BillionToOne is Series C Y Combinator, $125M Series C in 2022. Total tracked rounds: 1.
Is BillionToOne hiring right now?
Current hiring signal for BillionToOne: Open Roles.
Is BillionToOne Team's profile verified?
Yes. BillionToOne Team's profile is marked as verified on 100Xfounder as of March 3, 2026.
How can I connect with BillionToOne Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for www.billiontoone.com.
What technologies are associated with BillionToOne?
BillionToOne is associated with Python, GCP, BigQuery, and React based on current profile intelligence.